Blog

On April 1, 2020, The Food and Drug Administration (FDA) recommended the universal recall of all Zantac and ranitidine products from the U.S. market. The Zantac recall comes after various third party tests have found that unsafe levels of the probable human carcinogen NDMA can be produced in Zantac and ranitidine products as they are stored…

On February 13, 2020, the Food and Drug Administration (FDA) requested a recall of the prescription weight loss medications Belviq (lorcaserin) and Belviq XR after a study associated long term use with certain cancers. Belviq’s manufacturer, the Japanese pharmaceutical company Eisai Inc., voluntarily recalled the drug in response to the FDA’s recommendation. What Is Belviq? Belviq was…

Johnson & Johnson knew for decades that there was asbestos in its talcum powder, according to a Reuters investigation released on December 14. This explosive development could dramatically impact the outcome for thousands of people who have filed lawsuits against J&J claiming that their mesothelioma or ovarian cancer was caused by J&J’s talcum powder. The…

Pharmaceutical company Mylan is recalling some of its blood pressure medications due to cancer concerns. The medications recalled all contain Valsartan. Since July 2018, the FDA has been recalling Valsartan due to finding trace amounts of N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA), which are classified as probable human carcinogens by the Environmental Protection Agency. Mylan has recalled…

In July 2018, the blood pressure medication Valsartan was recalled due to contamination with a probable human carcinogen. The FDA estimates that between 3 and 3.7 million people have been prescribed Valsartan over the last three years. Many are scared and wondering what side effects this contaminated medication could cause. What Are the Valsartan…

Plaintiffs in the ongoing St. Louis Johnson & Johnson talcum powder trial have alleged that J&J secretly funded research that concluded talcum powder does not cause ovarian cancer. The research was conducted by researchers retained by Crowell & Moring LLP, a law firm also retained by Luzenac, now known as Imerys. Imerys is J&J’s…